CBDL 0.00 CBD Life Sciences Inc.

Stock List / CBD Life Sciences Inc.

Range:	4.0E-4-0.03	Vol Avg:	15682102	Last Div:	0	Changes:	0
Beta:	56.59	Cap:	0.00B	Currency:	USD	Exchange:	PNK
Sector:	Healthcare			IPO:	Fri Sep 11 2009	Empoloyees:	4
CUSIP:	12482V103	CIK:	0001776073	ISIN:	US12482V1035	Country:	US
CEO:	Ms. Lisa Anne Nelson			Website:	https://lbcbioscienceinc.com

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Stock Details

Positive 0.39

CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance

As the global CBD market is projected to reach $47 billion by 2028, CBDL's groundbreaking ...

accesswire.com·Thu Oct 17 2024

Positive 0.39

CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement

CBD Life Sciences propels its expansion with a major MOU, positioning the company for mult...

accesswire.com·Tue Oct 15 2024

Positive 0.20

CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products

Leveraging Alibaba's 1.28 billion annual active consumers and $3 trillion in gross merchan...

accesswire.com·Thu Oct 10 2024

Positive 0.57

CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

"Record-breaking revenue, new market entries, and transformative partnerships highlight ou...

accesswire.com·Tue Oct 08 2024

Positive 0.35

CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness

The annual economic impact of the equine industry is significant - involving some $300 bil...

accesswire.com·Thu Oct 03 2024

Positive 0.16

CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements

With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences...

accesswire.com·Tue Oct 01 2024

Positive 0.44

CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024

The U.S. CBD consumer health market size was estimated at USD 7.81 billion in 2023 and is ...

accesswire.com·Thu Sep 26 2024

Positive 0.31

CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace

Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valu...

accesswire.com·Tue Sep 24 2024

Positive 0.46

CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness

Projected to increase company revenue by 20% in the first year, capitalizing on the boomin...

accesswire.com·Tue Sep 17 2024

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.